BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1372 related articles for article (PubMed ID: 25329139)

  • 1. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P; Merlen E; Robert Y; Cortet-Rudelli C; Decanter C; Jonard S; Dewailly D
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
    Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
    Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.
    Eldar-Geva T; Margalioth EJ; Gal M; Ben-Chetrit A; Algur N; Zylber-Haran E; Brooks B; Huerta M; Spitz IM
    Hum Reprod; 2005 Jul; 20(7):1814-9. PubMed ID: 15802320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X; Pang Y; Qiao J
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study.
    Lv PP; Jin M; Rao JP; Chen J; Wang LQ; Huang CC; Yang SQ; Yao QP; Feng L; Shen JM; Feng C
    BMC Endocr Disord; 2020 Jul; 20(1):101. PubMed ID: 32641160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.